Stockscreener 앱 받기
4.14
0.00%
0.00
시간 외 거래:
4.20
0.06
+1.45%
전일 마감가:
$4.14
열려 있는:
$4.13
하루 거래량:
22,525
Relative Volume:
0.52
시가총액:
$34.53M
수익:
$7.50M
순이익/손실:
$-7.79M
주가수익비율:
-3.3601
EPS:
-1.2321
순현금흐름:
$-24.56M
1주 성능:
+1.97%
1개월 성능:
-2.82%
6개월 성능:
-62.40%
1년 성능:
+206.67%
1일 변동 폭
$3.97
$4.145
1주일 범위
$3.8801
$4.51
52주 변동 폭
$1.25
$12.15
에바종 바이오테크 Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
4.14 | 34.53M | 7.50M | -7.79M | -24.56M | -1.2321 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
에바종 바이오테크 Stock (EVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Maxim Group | Buy |
| 2024-04-02 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | 개시 | H.C. Wainwright | Buy |
에바종 바이오테크 주식(EVAX)의 최신 뉴스
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 - GlobeNewswire Inc.
Endesa S.A. – Unsponsored ADR (OTCMKTS:ELEZY) Given Average Rating of “Strong Sell” by Brokerages - Defense World
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
European ADRs Rose, While Biotech Names Did The Heavy Lifting - Finimize
Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks
Evaxion A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright - Defense World
Evaxion A/S (NASDAQ:EVAX) Price Target Cut to $9.00 by Analysts at Lake Street Capital - Defense World
Evaxion Earnings Report: Q4 Overview - Sahm
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Short Interest Up 20.9% in February - Defense World
Evaxion Biotech's Earnings: A Preview - Sahm
European ADRs Slip Slightly As Winners And Losers Split - Finimize
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Target Price at $12.33 - Defense World
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Sahm
European Firms Make Gains On US Markets As ADR Index Rises - Finimize
Evaxion Biotech Reports Strong Q3 2025 Results - MSN
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Price Target at $12.33 - Defense World
European ADRs Edge Up With Gains Led By Evaxion - Finimize
Evaxion Biotech’s Earnings Call Highlights Strategic Growth - TipRanks
Analysts Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) PT at $12.33 - Defense World
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
에바종 바이오테크 (EVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):